These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
961 related items for PubMed ID: 9173910
21. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Joachim CL, Mori H, Selkoe DJ. Nature; 1989 Sep 21; 341(6239):226-30. PubMed ID: 2528696 [Abstract] [Full Text] [Related]
22. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA. Neurobiol Aging; 2004 Sep 21; 25(10):1263-72. PubMed ID: 15465622 [Abstract] [Full Text] [Related]
23. Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4. Munoz DG, Wang D. Am J Pathol; 1992 May 21; 140(5):1167-78. PubMed ID: 1580329 [Abstract] [Full Text] [Related]
24. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Navarro A, Del Valle E, Astudillo A, González del Rey C, Tolivia J. Exp Neurol; 2003 Dec 21; 184(2):697-704. PubMed ID: 14769361 [Abstract] [Full Text] [Related]
25. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice. Kulnane LS, Lamb BT. Neurobiol Dis; 2001 Dec 21; 8(6):982-92. PubMed ID: 11741394 [Abstract] [Full Text] [Related]
26. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age. Fonseca MI, Head E, Velazquez P, Cotman CW, Tenner AJ. Exp Neurol; 1999 Jun 21; 157(2):277-88. PubMed ID: 10364440 [Abstract] [Full Text] [Related]
27. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T, Kiliaan AJ, Kadish I. Neurobiol Dis; 2006 Sep 21; 23(3):653-62. PubMed ID: 16829076 [Abstract] [Full Text] [Related]
28. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Botella-López A, Cuchillo-Ibáñez I, Cotrufo T, Mok SS, Li QX, Barquero MS, Dierssen M, Soriano E, Sáez-Valero J. Neurobiol Dis; 2010 Mar 21; 37(3):682-91. PubMed ID: 20025970 [Abstract] [Full Text] [Related]
29. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease. Noda-Saita K, Terai K, Iwai A, Tsukamoto M, Shitaka Y, Kawabata S, Okada M, Yamaguchi T. Acta Neuropathol; 2004 Nov 21; 108(5):435-42. PubMed ID: 15372280 [Abstract] [Full Text] [Related]
30. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F. Neurobiol Aging; 2004 Aug 21; 25(7):861-71. PubMed ID: 15212840 [Abstract] [Full Text] [Related]
31. Brain site-specific gene expression analysis in Alzheimer's disease patients. Yokota T, Mishra M, Akatsu H, Tani Y, Miyauchi T, Yamamoto T, Kosaka K, Nagai Y, Sawada T, Heese K. Eur J Clin Invest; 2006 Nov 21; 36(11):820-30. PubMed ID: 17032350 [Abstract] [Full Text] [Related]
32. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y. Ann Neurol; 1995 Mar 21; 37(3):294-9. PubMed ID: 7695229 [Abstract] [Full Text] [Related]
33. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K. N Engl J Med; 1995 Nov 09; 333(19):1242-7. PubMed ID: 7566000 [Abstract] [Full Text] [Related]
34. Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Ikeda S, Allsop D, Glenner GG. Lab Invest; 1989 Jan 09; 60(1):113-22. PubMed ID: 2642985 [Abstract] [Full Text] [Related]
35. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T, Kinoshita T, Arima K. Neuropathol Appl Neurobiol; 2006 Oct 09; 32(5):539-56. PubMed ID: 16972888 [Abstract] [Full Text] [Related]
36. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Esler WP, Stimson ER, Ghilardi JR, Vinters HV, Lee JP, Mantyh PW, Maggio JE. Biochemistry; 1996 Jan 23; 35(3):749-57. PubMed ID: 8547255 [Abstract] [Full Text] [Related]
37. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex. Yilmazer-Hanke DM. Acta Anat (Basel); 1998 Jan 23; 162(1):46-55. PubMed ID: 9789108 [Abstract] [Full Text] [Related]
38. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Neurobiol Dis; 2005 Nov 23; 20(2):574-82. PubMed ID: 15916898 [Abstract] [Full Text] [Related]
39. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA, Nafe R, Schlote W. Brain Res; 2008 Jun 05; 1213():152-65. PubMed ID: 18455153 [Abstract] [Full Text] [Related]
40. Frameshift proteins in autosomal dominant forms of Alzheimer disease and other tauopathies. van Leeuwen FW, van Tijn P, Sonnemans MA, Hobo B, Mann DM, Van Broeckhoven C, Kumar-Singh S, Cras P, Leuba G, Savioz A, Maat-Schieman ML, Yamaguchi H, Kros JM, Kamphorst W, Hol EM, de Vos RA, Fischer DF. Neurology; 2006 Jan 24; 66(2 Suppl 1):S86-92. PubMed ID: 16432153 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]